Optimizing SARS-CoV-2 Testing and Promotores Interventions to Serve Latinx Communities

Information

  • Research Project
  • 10414385
  • ApplicationId
    10414385
  • Core Project Number
    P50DA048756
  • Full Project Number
    3P50DA048756-03S3
  • Serial Number
    048756
  • FOA Number
    PA-20-135
  • Sub Project Id
  • Project Start Date
    9/15/2021 - 3 years ago
  • Project End Date
    8/31/2023 - a year ago
  • Program Officer Name
    CRUMP, ARIA
  • Budget Start Date
    9/15/2021 - 3 years ago
  • Budget End Date
    8/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    03
  • Suffix
    S3
  • Award Notice Date
    9/9/2021 - 3 years ago
Organizations

Optimizing SARS-CoV-2 Testing and Promotores Interventions to Serve Latinx Communities

PROJECT SUMMARY The global SARS-CoV-2 pandemic is the worst health crisis the United States and world have faced in a century. Although this highly contagious virus has infected tens of millions of Americans already, the pandemic is far from over, and the disease burdens continue to be disproportionately born by historically underserved populations such as Latinx communities. Nationally, Latinx people with COVID-19 are hospitalized at four times the rate of Whites and have much higher rates of morbidity and mortality. This disparity is notable in Oregon, where the 13% of our population that is Latinx represents approximately 24% of COVID-19 cases. Yet, vaccination rates for Latinx remain below the state average. Thus, an urgent need exists to reach Oregon?s Latinx community with public health and prevention messages that emphasize the value of continued COVID-19 testing and that address vaccine hesitancy. This project will build upon our successful RADx-UP Phase I culturally-tailored community outreach and testing program through the implementation of Phase II goals of increasing the reach and uptake of testing and decreasing vaccine hesitancy in Latinx individuals in Oregon. The project will maintain and expand a world-class team of prevention scientists, public health experts, Latinx researchers, community partners, and biologists who have been working together to conduct SARS-CoV-2 diagnostic testing since March 2020. This team established a CLIA-certified laboratory and honed molecular testing protocols, procured millions of dollars of diagnostic testing equipment and supplies, and partnered with county public health offices and hospitals throughout the state to conduct testing. The team has been engaged in comprehensive community partnerships using community-based participatory research methods in Phase I to deliver a culturally-tailored intervention that shows preliminary efficacy in increasing testing among Latinx individuals. Building on the lessons learned in the first 6 months of our Phase I RADX-UP testing, we will refocus our existing testing program to broaden our reach by partnering with state and community organizations offering other services to Latinx communities across Oregon. With continued support from the Latinx Community and Scientific Advisory Board, the project will refocus to support the testing of 100 individuals each month across the state of Oregon, focusing specifically on locating testing events at venues that serve Latinx individuals (e.g., mobile Mexican Consulate events across the state). The previously launched health intervention (Promotores de Salud) will also be refocused to promote the benefits of continued testing and vaccination uptake, and barriers to these important health behaviors will be evaluated. Over time, this project will continue to help communities institutionalize optimal local testing frameworks that are sustainable. The resulting testing and structures and systems will be poised for future scale-up to other vulnerable communities and/or for other public health purposes. This project is expected to lead to a major reduction in COVID-19 health disparities in underserved populations.

IC Name
NATIONAL INSTITUTE ON DRUG ABUSE
  • Activity
    P50
  • Administering IC
    DA
  • Application Type
    3
  • Direct Cost Amount
    748851
  • Indirect Cost Amount
    355704
  • Total Cost
    1104555
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    279
  • Ed Inst. Type
    ORGANIZED RESEARCH UNITS
  • Funding ICs
    OD:1104555\
  • Funding Mechanism
    RESEARCH CENTERS
  • Study Section
    ZMD1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    UNIVERSITY OF OREGON
  • Organization Department
    PSYCHOLOGY
  • Organization DUNS
    079289626; 948117312
  • Organization City
    EUGENE
  • Organization State
    OR
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    974035219
  • Organization District
    UNITED STATES